JAMA Neurology Author Interviews podcast

Fremanezumab for the Treatment of Migraine and Major Depressive Disorder

0:00
21:13
Rewind 15 seconds
Fast Forward 15 seconds

Interview with Richard B. Lipton, MD, author of Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder. Hosted by Cynthia E. Armand, MD.

Related Content:

More episodes from "JAMA Neurology Author Interviews"